Ervogastat (PF-06865571) is a potent diacylglycerol acyltransferase 2 inhibitor (DGAT2i) that reduces steatosis and hepatic triglyceride levels in non-alcoholic steatohepatitis (NASH).
Storage Temp
Store at -20°C
Shipped In
Ice chest + Ice pads
Grade
Moligand™
Action Type
INHIBITOR
Mechanism of action
Inhibitor of diacylglycerol O-acyltransferase 2
Product Description
Information
Ervogastat (PF-06865571) is a potent diacylglycerol acyltransferase 2 inhibitor (DGAT2i) that reduces steatosis and hepatic triglyceride levels in non-alcoholic steatohepatitis (NASH).
1.Futatsugi K, Cabral S, Kung DW, Huard K, Lee E, Boehm M, Bauman J, Clark RW, Coffey SB, Crowley C et al.. (2022) Discovery of Ervogastat (PF-06865571): A Potent and Selective Inhibitor of Diacylglycerol Acyltransferase 2 for the Treatment of Non-alcoholic Steatohepatitis.. J Med Chem, 129 (3):(589-97). [PMID:36322383]
Solution Calculators
Molarity Calculator
Determine the necessary mass, volume, or concentration for preparing a solution.
Dilution Calculator
Determine the dilution needed to prepare a stock solution.